Listed

PureTech Health plc: Form 20-F for the period ended Dec 31, 2023

Filed with the SEC on Apr 25, 2024 and accepted by EDGAR at Apr 25, 2024, 11:57 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2023-01-01 to 2023-12-31$3.3mifrs-full:Revenue
Operating income12 months2023-01-01 to 2023-12-31−$146.2mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2023-01-01 to 2023-12-31$30.5mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2023-01-01 to 2023-12-31−$65.7mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2023-01-01 to 2023-12-31−$0.24ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2023-01-01 to 2023-12-31−$0.24ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2023-01-01 to 2023-12-31−$105.9mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2023-01-01 to 2023-12-31$70.0kifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2023-12-31$191.1mifrs-full:CashAndCashEquivalents
Current assetsAt period end2023-12-31$347.2mifrs-full:CurrentAssets
Total assetsAt period end2023-12-31$694.0mifrs-full:Assets
Current liabilitiesAt period end2023-12-31$51.4mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2023-12-31$235.7mifrs-full:Liabilities
Shareholders' equityAt period end2023-12-31$464.1mifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2023-12-31271,853,731 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001628280-24-017913. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.